<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Limited knowledge exists about the impact of specific genetic abnormalities on the proliferation of neoplastic B cells from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (B-CLPDs) </plain></SENT>
<SENT sid="1" pm="."><plain>Here we analyze the impact of cytogenetic abnormalities on the proliferation of neoplastic B cells in 432 B-CLPD patients, grouped according to diagnosis and site of sampling, versus their <z:mpath ids='MPATH_458'>normal</z:mpath> counterparts </plain></SENT>
<SENT sid="2" pm="."><plain>Overall, proliferation of neoplastic B cells highly varied among the different B-CLPD subtypes, the greatest numbers of proliferating cells being identified in diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with <z:mpath ids='MPATH_458'>normal</z:mpath> B cells, neoplastic B-CLPD cells showed significantly increased S + G(2)/M-phase values in mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>), B-<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (B-CLL), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, and some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>Conversely, decreased proliferation was observed in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:e sem="disease" ids="C0024419" disease_type="Neoplastic Process" abbrv="">Waldenstr√∂m macroglobulinemia</z:e> (LPL/WM), and some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> patients; hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, splenic marginal zone, and MALT-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients showed S + G(2)/M phase values similar to <z:mpath ids='MPATH_458'>normal</z:mpath> mature B lymphocytes from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, in B-CLL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> significantly higher percentages of S + G(2)/M cells were detected in BM versus PB and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> versus BM and PB samples, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>In turn, presence of 14q32.3 gene rearrangements and DNA <z:mp ids='MP_0004024'>aneuploidy</z:mp>, was associated with a higher percentage of S + G(2)/M-phase cells among LPL/WM and B-CLL cases, respectively </plain></SENT>
</text></document>